000			01397nam a2200169Ia 4500
003			MX-MdCICY
005			20250625153913.0
040			_cCICY
090			_aB-12959
245	1	0	_aModern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation
490	0		_vJournal of Natural Products, 74(3), p.496-511, 2011
520	3		_aNatural products continue to provide a diverse and unique source of bioactive lead compounds for drug discovery, but maintaining their continued eminence as source compounds is challenging in the face of the changing face of the pharmaceutical industry and the changing nature of biodiversity prospecting brought about by the Convention on Biological Diversity. This review provides an overview of some of these challenges and suggests ways in which they can be addressed so that natural products research can remain a viable and productive route to drug discovery. Results from International Cooperative Biodiversity Groups ICBGs)working in Madagascar, Panama, and Suriname are used as examples of what can be achieved when biodiversity conservation is linked to drug discovery.
700	1	2	_aKingston, D.G.I.
856	4	0	_uhttps://drive.google.com/file/d/1mYAUGMppt6fHZLfAIRkY7Nkjl2ntuYpI/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c47161 _d47161